Preconception 1-hour blood glucose as an early indicator of gestational diabetes mellitus risk in PMOS/PCOS women undergoing IVF treatment: a multi-centre cohort study
Human Reproduction · 2026
DOI: 10.1093/humrep/deag119 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Human Reproduction, 2026. Verfasst von Guiquan Wang und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Reproductive Medicine, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, China. Hauptthemen laut MEDLINE: Blood Glucose, Diabetes, Gestational, Fertilization in Vitro, Polycystic Ovary Syndrome. Die Arbeit nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Fujian Province, Yongjiang Science and Technology Innovation 2035.
Themen: Diabetes mellitus
Abstract (Originalsprache)
STUDY QUESTION Is the preconception 1-h plasma glucose level during the oral glucose tolerance test (OGTT) more strongly associated with subsequent gestational diabetes mellitus than the fasting or 2-h glucose levels in women with PMOS/PCOS undergoing IVF treatment? SUMMARY ANSWER Preconception 1-h plasma glucose showed a stronger and more consistent association with gestational diabetes mellitus than the fasting or 2-h glucose levels in women with PMOS/PCOS undergoing IVF treatment. WHAT IS KNOWN ALREADY Women with PMOS/PCOS have an increased risk of gestational diabetes mellitus. International guidelines recommend a preconception OGTT in women with PMOS/PCOS without pre-existing diabetes because of the risk of hyperglycaemia and pregnancy complications. However, the comparative predictive value of different preconception OGTT time points, particularly 1-h glucose, remains unclear. STUDY DESIGN, SIZE, DURATION This was a multi-centre retrospective cohort study including 2571 women with PMOS/PCOS who underwent their first IVF treatment at three reproductive medicine centres in China and had a preconception 75-g OGTT between March 2018 and December 2023. PARTICIPANTS/MATERIALS, SETTING, METHODS Women with PMOS/PCOS who completed a preconception 75-g OGTT before initiation of the IVF treatment were included. The primary outcome was GDM diagnosed at 24–28 weeks of gestation. Generalized linear mixed-effects models were used to assess associations between OGTT glucose levels and GDM, adjusting for age, BMI, infertility duration, hormonal profiles, and treatment protocols. Stratified analyses by BMI and PMOS/PCOS phenotype were conducted, and multiple imputation was applied for missing data. MAIN RESULTS AND THE ROLE OF CHANCE Preconception fasting (aOR 1.97 [1.49–2.61]), 1-h (aOR 1.23 [1.13–1.34]) and 2-h glucose (aOR 1.30 [1.17–1.45]) were all significantly associated with GDM (all P < 0.001). Within the diabetic range, only the 1-h glucose measurement of ≥11.6 mmol/l remained a significant indicator. The association of 1-h glucose with GDM was significant in normal-weight and obese women but not in overweight women. The associations were consistent across PMOS/PCOS phenotypes. LIMITATIONS, REASONS FOR CAUTION The retrospective design may have introduced residual confounding and limits causal inference. Missing data required imputation, and subgroup analyses may have limited statistical power. WIDER IMPLICATIONS OF THE FINDINGS These findings suggest that preconception 1-h glucose may provide additional value for identifying women who are a higher risk of GDM among normal-weight and obese women with PMOS/PCOS undergoing IVF treatment, and support its consideration in preconception metabolic assessments. FUNDING This work was supported by the National Natural Science Foundation of China (82522038, 82471670 and 82401908), the Natural Science Foundation of Fujian Province (2025J011428), and the “Yongjiang Science and Technology Innovation 2035” Key Research and Development Program (2025Z151). DISCLOSURES The authors declared no competing interests. TRIAL REGISTRATION NUMBER N/A
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Reproductive Medicine, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, China.
- Xiamen Key Laboratory of Reproduction and Genetics, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, China.
- Department of Pediatric Surgery, Pediatric Center, Zhongshan Hospital, Fudan University, Shanghai, China.
- Reproductive Medicine Center, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
- Center for Reproductive Medicine, Women and Children's Hospital of Ningbo University, Ningbo, China.
- Department of Endocrinology and Metabolism, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
ORCID-Profile: Guiquan Wang, Yi Chen, Xiaoling Liang, Zimiao Chen, Liangshan Mu
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Fujian Province
- Yongjiang Science and Technology Innovation 2035
- Key Research and Development Program
Zitieren
APA
Wang, G., Xie, L., Chen, Y., Ding, Z., Gao, H., Yang, H., Wang, P., Gong, X., Ji, X., Wang, L., He, L., Xie, W., Xin, L., Dai, H., Dong, X., Li, P., Zhou, L., Shi, J., Liang, X., …, & Mu, L. (2026). Preconception 1-hour blood glucose as an early indicator of gestational diabetes mellitus risk in PMOS/PCOS women undergoing IVF treatment: a multi-centre cohort study. Human Reproduction. https://doi.org/10.1093/humrep/deag119
Vancouver
Wang G, Xie L, Chen Y, Ding Z, Gao H, Yang H, et al. Preconception 1-hour blood glucose as an early indicator of gestational diabetes mellitus risk in PMOS/PCOS women undergoing IVF treatment: a multi-centre cohort study. Human Reproduction. 2026. doi:10.1093/humrep/deag119
BibTeX
@article{Wang2026,
author = {Wang, Guiquan and Xie, Lulu and Chen, Yi and Ding, Ziyin and Gao, Haijie and Yang, Haiyan and Wang, Peiyu and Gong, Xiaohua and Ji, Xiaowei and Wang, Lin and He, Liying and Xie, Wanyi and Xin, Luping and Dai, Haiping and Dong, Xi and Li, Ping and Zhou, Liming and Shi, Juanzi and Liang, Xiaoling and Chen, Zimiao and Mu, Liangshan},
title = {Preconception 1-hour blood glucose as an early indicator of gestational diabetes mellitus risk in PMOS/PCOS women undergoing IVF treatment: a multi-centre cohort study},
journal = {Human Reproduction},
year = {2026},
doi = {10.1093/humrep/deag119}
}
EUVIMED